Prediction of cognitive decline based on hemispheric cortical surface maps of FDDNP PET

NeuroImage

Volumn 61, Issue 4, 2012, Pages 749-760

  Protas, Hillary D ^a   Kepe, Vladimir ^a   Hayashi, Kiralee M ^a   Klunder, Andrea D ^a   Braskie, Meredith N ^a   Ercoli, Linda ^a   Siddarth, Prabha ^a   Bookheimer, Susan Y ^a   Thompson, Paul M ^a   Small, Gary W ^a   Barrio, Jorge R ^a   Huang, Sung Cheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cortical surface maps; FDDNP PET; MMSE; MR

Indexed keywords

2( 1 (6 [(2 FLUOROETHYL)(METHYL)AMINO] 2 NAPHTHYL)ETHYLIDENE)MALONONITRILE; AMYLOID BETA PROTEIN; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN MAPPING; BRAIN PERFUSION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISTRIBUTION VOLUME; FEMALE; HEMISPHERE; HUMAN; MALE; MATHEMATICAL MODEL; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROANATOMY; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PREDICTIVE VALIDITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; TEMPORAL CORTEX;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; CROSS-SECTIONAL STUDIES; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES;

EID: 84861161712     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.02.056     Document Type: Article

References (38)

1. American Psychological Association Diagnosis and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision) Washington DC 2000.
2. Apostolova L.G., Thompson P.M., Rogers S.A., Dinov I.D., Zoumalan C., Steiner C.A., Siu E., Green A.E., Small G.W., Toga A.W., Cummings J.L., Phelps M.E., Silverman D.H. Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly. Mol. Imaging Biol. 2010, 12:218-224.
3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
4. Braskie M.N., Klunder A.D., Hayashi K.M., Protas H., Kepe V., Miller K.J., Huang S.C., Barrio J.R., Ercoli L.M., Siddarth P., Satyamurthy N., Liu J., Toga A.W., Bookheimer S.Y., Small G.W., Thompson P.M. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol. Aging 2010, 31:1669-1678.
5. Buschke H., Fuld P.A. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974, 24:1019-1025.
6. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 1994, 18:192-205.
7. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11050-11055.
8. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
9. Frackowiak R.S.J. Human Brain Function 2004, Academic Press, San Diego, Calif. 2nd ed.
10. Hastie T., Tibshirani R., Friedman J.H. The Elements of Statistical Learning Data Mining, Inference, and Prediction 2009, xxii. SpringerLink (Online service), Springer, New York, 745 pp.
11. Kemppainen N.M., Aalto S., Wilson I.A., Nagren K., Helin S., Bruck A., Oikonen V., Kailajarvi M., Scheinin M., Viitanen M., Parkkola R., Rinne J.O. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 2007, 68:1603-1606.
12. Kepe V., Huang S.C., Small G.W., Satyamurthy N., Barrio J.R. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease. Methods Enzymol. 2006, 412:144-160.
13. Leinonen V., Alafuzoff I., Aalto S., Suotunen T., Savolainen S., Nagren K., Tapiola T., Pirttila T., Rinne J., Jaaskelainen J.E., Soininen H., Rinne J.O. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch. Neurol. 2008, 65:1304-1309.
14. Liu J., Kepe V., Zabjek A., Petric A., Padgett H.C., Satyamurthy N., Barrio J.R. High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononi trile ([18F]FDDNP) ready for animal or human administration. Mol. Imaging Biol. 2007, 9:6-16.
15. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
16. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., Woods R., Paus T., Simpson G., Pike B., Holmes C., Collins L., Thompson P., MacDonald D., Iacoboni M., Schormann T., Amunts K., Palomero-Gallagher N., Geyer S., Parsons L., Narr K., Kabani N., Le Goualher G., Boomsma D., Cannon T., Kawashima R., Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356:1293-1322.
17. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 1997, 42:85-94.
18. Mintun M.A., Larossa G.N., Sheline Y.I., Dence C.S., Lee S.Y., Mach R.H., Klunk W.E., Mathis C.A., DeKosky S.T., Morris J.C. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006, 67:446-452.
19. O'Leary D.P. Robust regression computation using iteratively reweighted least squares. SIAM J. Matrix Anal. Appl. 1990, 11:466-480.
20. Osterrieth P. Le test de copie d'une figure complexe. Arch. Psychol. (Geneve) 1944, 30:206-356.
21. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256:183-194.
22. Petrella J.R., Coleman R.E., Doraiswamy P.M. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003, 226:315-336.
23. Protas H.D., Huang S.C., Kepe V., Hayashi K., Klunder A., Braskie M.N., Ercoli L., Bookheimer S., Thompson P.M., Small G.W., Barrio J.R. FDDNP binding using MR derived cortical surface maps. NeuroImage 2010, 49:240-248.
24. Rasser P.E., Johnston P., Lagopoulos J., Ward P.B., Schall U., Thienel R., Bender S., Toga A.W., Thompson P.M. Functional MRI BOLD response to Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. NeuroImage 2005, 26:941-951.
25. Shin J., Lee S.Y., Kim S.H., Kim Y.B., Cho S.J. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease. NeuroImage 2008, 43:236-244.
26. Small G.W., Kepe V., Ercoli L.M., Siddarth P., Bookheimer S.Y., Miller K.J., Lavretsky H., Burggren A.C., Cole G.M., Vinters H.V., Thompson P.M., Huang S.C., Satyamurthy N., Phelps M.E., Barrio J.R. PET of brain amyloid and tau in mild cognitive impairment. N. Engl. J. Med. 2006, 355:2652-2663.
27. Small G.W., Bookheimer S.Y., Thompson P.M., Cole G.M., Huang S.C., Kepe V., Barrio J.R. Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol. 2008, 7:161-172.
28. Sowell E.R., Thompson P.M., Mega M.S., Zoumalan C.I., Lindshield C.J., Rex D.E. Gyral pattern delineation in 3D: surface curve protocol http://www.loni.ucla.edu/~esowell/new_sulcvar.html.
29. Sowell E.R., Thompson P.M., Rex D., Kornsand D., Tessner K.D., Jernigan T.L., Toga A.W. Mapping sulcal pattern asymmetry and local cortical surface gray matter distribution in vivo: maturation in perisylvian cortices. Cereb. Cortex 2002, 12:17-26.
30. Thompson P.M., MacDonald D., Mega M.S., Holmes C.J., Evans A.C., Toga A.W. Detection and mapping of abnormal brain structure with a probabilistic atlas of cortical surfaces. J. Comput. Assist. Tomogr. 1997, 21:567-581.
31. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., Toga A.W. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 2003, 23:994-1005.
32. Thompson P.M., Hayashi K.M., Sowell E.R., Gogtay N., Giedd J.N., Rapoport J.L., de Zubicaray G.I., Janke A.L., Rose S.E., Semple J., Doddrell D.M., Wang Y., van Erp T.G., Cannon T.D., Toga A.W. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. NeuroImage 2004, 23(Suppl 1):S2-S18.
33. Van Essen D.C., Drury H.A. Structural and functional analyses of human cerebral cortex using a surface-based atlas. J. Neurosci. 1997, 17:7079-7102.
34. Wardak M., Wong K.P., Shao W., Dahlbom M., Kepe V., Satyamurthy N., Small G.W., Barrio J.R., Huang S.C. Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans. J. Nucl. Med. 2010, 51:210-218.
35. Wong K.P., Wardak M., Shao W., Zhou Z., Dahlbom M., Smid L., Truong D., Kepe V., Small G.W. Movement Correction of [18F]FDDNP PET Studies for Brain Amyloid. Nuclear Science Symposium Conference Record,2007,NSS'07,IEEE 5 2007, 3974-3977.
36. Wong K.P., Wardak M., Shao W., Dahlbom M., Kepe V., Liu J., Satyamurthy N., Small G.W., Barrio J.R., Huang S.C. Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:575-588.
37. Wu H.M., Shoghi-Jadid K., Kepe V., Small G.W., Barrio J.R., Huang S.C. "Diagnostic index" parametric images using [F-18]FDDNP-PET in Alzheimer's disease(AD)-a new and simplified procedure. J. Nucl. Med. 2004, 45:68.
38. Yaqub M., Boellaard R., van Berckel B.N., Tolboom N., Luurtsema G., Dijkstra A.A., Lubberink M., Windhorst A.D., Scheltens P., Lammertsma A.A. Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies. Mol. Imaging Biol. 2009, 11:322-333.